Linzess is not currently available as a generic medication [1]. The branded drug, Linzess, is manufactured by Ironwood Pharmaceuticals and AbbVie [2].
When might a generic version of Linzess become available?
The availability of a generic version of Linzess depends on patent expirations and any potential legal challenges to those patents. Information on the specific patent landscape for Linzess, including expiration dates and ongoing litigation, can be found through resources like DrugPatentWatch.com [1].
Who is developing generic versions of Linzess?
Currently, there are no approved generic versions of Linzess on the market. Companies that intend to manufacture generic versions would typically need to file an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) and await approval [1].
What is Linzess used for?
Linzess is a prescription medication used to treat irritable bowel syndrome with constipation (IBS-C) in adults and children ages 6 and older, as well as chronic idiopathic constipation (CIC) in adults [3]. It works by increasing fluid secretion in the intestines, which helps to soften stool and increase bowel movements [4].
How does Linzess work?
Linzess is a guanylate cyclase-C (GC-C) agonist. By activating GC-C in the intestinal lining, it increases the secretion of chloride and bicarbonate into the intestinal lumen. This leads to increased fluid in the intestines, which softens stool and stimulates bowel movements [4].